Is every laboratory test result a biomarker?

Not simply because it was measured. Under the FDA-NIH BEST definition, a biomarker is a defined characteristic measured as an indicator of a biological or disease process, or a response to an exposure or intervention. A useful description identifies the characteristic, its sample or matrix, the analytical method, and the intended role. The context gives the measurement its biomarker job.

What is the difference between a biomarker and a clinical outcome?

A biomarker measures a biological characteristic. A clinical outcome assessment directly describes how a person feels, functions, or survives. Some biomarkers may be used as surrogate endpoints when evidence supports that specific role, but the word biomarker alone does not establish clinical benefit. The intended context and level of validation must be stated rather than assumed.

What is the difference between predictive and prognostic biomarkers?

A prognostic biomarker indicates the likelihood of a future clinical event, recurrence, or progression in people who already have the condition of interest, without depending on a particular intervention. A predictive biomarker identifies people more likely to experience a favorable or unfavorable effect from a medical product or environmental exposure. One concerns likely course; the other concerns differential response.

Does FDA biomarker qualification apply to every use of that biomarker?

No. FDA qualification supports a specific interpretation and application within a stated context of use in medical-product development. It is not a universal approval for every population, purpose, or analytical method. The FDA also distinguishes qualification of the biomarker from qualification of the method used to measure it, so readers should check the exact qualification statement.

Biotech Basics

What Is a Biomarker? Seven Types in Plain English

Benchlight Science · Updated 2026-07-19 · 4 min read

AbstractA biomarker is a defined, measurable characteristic used as an indicator of a normal biological process, a disease process, or a response to an exposure or intervention. Biomarkers may be molecular, histologic, radiographic, or physiologic. Their meaning depends on the stated role, population, sample, analytical method, and context of use; a biomarker is not automatically a diagnosis or a direct measure of how a person feels, functions, or survives.

Contents

What Is a Biomarker?
What Are the Seven Biomarker Categories?
What Information Makes a Biomarker Claim Useful?
Is a Biomarker the Same as a Clinical Outcome?
What Does FDA Qualification Mean?
Sources

What Is a Biomarker?

A biomarker is a defined, measurable characteristic used as an indicator of a biological process, a disease process, or a response to an exposure or intervention. It may be molecular, histologic, radiographic, or physiologic. The useful question is not simply “What was measured?” but “What is this measurement meant to indicate in this setting?”

That definition comes from the FDA-NIH Biomarkers, EndpointS, and other Tools resource, usually shortened to BEST. It keeps the term broader than “blood test” and narrower than “anything we can count.” A scan feature, tissue characteristic, gene variant, or physiological measurement can be a biomarker when it has a defined indicator role.

A biomarker is a job description, not a fancy synonym for a laboratory result.

What Are the Seven Biomarker Categories?

The U.S. Food and Drug Administration lists seven BEST categories. The category describes what the marker is being used to do, so the same measured characteristic may have different roles in different contexts.

Category	What the biomarker indicates
Susceptibility or risk	The potential to develop a disease or condition in someone who does not currently have it clinically.
Diagnostic	The presence of a disease or condition, or a particular subtype.
Monitoring	Status measured repeatedly over time, including disease status or evidence of an exposure or effect.
Prognostic	The likelihood of a future clinical event, recurrence, or progression in people who already have the condition of interest.
Predictive	Which individuals are more likely to have a favorable or unfavorable effect from a medical product or environmental agent.
Pharmacodynamic or response	That a biological response, beneficial or harmful, occurred after an exposure to a medical product or environmental agent.
Safety	The likelihood, presence, or extent of toxicity after exposure to a medical product or environmental agent.

These labels can overlap. A measurement repeated during a study may be a monitoring biomarker, while its particular purpose could also make it a safety or response biomarker. Read the stated role rather than assigning a category from the marker's name alone.

What Information Makes a Biomarker Claim Useful?

The FDA says a full biomarker description includes the biomarker's name, its source or matrix, the characteristic being measured, and the analytical method. In plain English: what, from where, and measured how.

Then look for the context of use:

Population: Who or what was studied?
Purpose: Was the marker used for diagnosis, monitoring, prediction, safety, or another defined role?
Timing: Was it measured once, repeatedly, before an exposure, or after one?
Method: Which assay, scan, or other analytical procedure produced the value?
Decision boundary: What interpretation was supported, and under which conditions?

This is also where research-model language matters. A biomarker observed in cultured cells answers a question about that experimental system. It does not automatically carry the same interpretation in a living organism or a person.

Our research methods section focuses on those context clues because a precise noun can still sit inside an overconfident sentence.

Is a Biomarker the Same as a Clinical Outcome?

No. The FDA's definition says a biomarker is not a direct assessment of how a person feels, functions, or survives. A clinical outcome assessment and a biomarker therefore answer different questions.

Some response biomarkers are used as surrogate endpoints in trials, but “biomarker” does not mean “proven substitute for a clinical benefit.” BEST defines a surrogate endpoint as a biomarker used in place of a direct measure of how a patient feels, functions, or survives, with an expectation that it predicts benefit or harm based on evidence. The context and validation matter.

What Does FDA Qualification Mean?

In the FDA's drug-development program, qualification means a biomarker has gone through a formal regulatory process for a specific interpretation and application within a stated context of use. The FDA also makes a useful distinction: the biomarker is qualified, not automatically every method that might measure it.

Qualification is therefore not a universal stamp for every population, assay, or purpose. When reading a claim, check the exact context instead of letting the word “qualified” do more work than the evidence.

For a personal test result, the relevant interpretation depends on the test, units, reference information, health context, and reason it was ordered. That question belongs with the clinician responsible for the test, not a general terminology guide.

Sources

FDA — About Biomarkers and Qualification: BEST definition, characteristic types, seven categories, full biomarker descriptions, context of use, and qualification scope.
FDA-NIH Biomarker Working Group — BEST Resource: formal category definitions, overlap between roles, response biomarkers, and the distinction between biomarkers and surrogate endpoints.

An independent publication. Not affiliated with any prior owner of this domain.